메뉴 건너뛰기




Volumn 90, Issue 1, 2012, Pages

Three versus one intravitreal bevacizumab injections as initial protocol to treat myopic choroidal neovascularization

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB;

EID: 84856532935     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2010.02070.x     Document Type: Letter
Times cited : (17)

References (4)
  • 1
    • 62249157089 scopus 로고    scopus 로고
    • Anty-VEGF therapy in the treatment of myopic macular choroidal neovascularization - Cases report
    • Figurska M, &, Stankiewicz A, (2008): Anty-VEGF therapy in the treatment of myopic macular choroidal neovascularization-cases report. Klin Oczna 110: 387-391.
    • (2008) Klin Oczna , vol.110 , pp. 387-391
    • Figurska, M.1    Stankiewicz, A.2
  • 2
    • 57549110464 scopus 로고    scopus 로고
    • Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results
    • e81.
    • Gharbiya M, Allievi F, Mazzeo L, &, Gabrieli CB, (2009): Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results. Am J Ophthalmol 147: 84-93. e81.
    • (2009) Am J Ophthalmol , vol.147 , pp. 84-93
    • Gharbiya, M.1    Allievi, F.2    Mazzeo, L.3    Gabrieli, C.B.4
  • 3
    • 57549094194 scopus 로고    scopus 로고
    • Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: One-year results
    • e101.
    • Ikuno Y, Sayanagi K, Soga K, Sawa M, Tsujikawa M, Gomi F, &, Tano Y, (2009a): Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results. Am J Ophthalmol 147: 94-100. e101.
    • (2009) Am J Ophthalmol , vol.147 , pp. 94-100
    • Ikuno, Y.1    Sayanagi, K.2    Soga, K.3    Sawa, M.4    Tsujikawa, M.5    Gomi, F.6    Tano, Y.7
  • 4
    • 70350440689 scopus 로고    scopus 로고
    • Angiographic changes after bevacizumab
    • Ikuno Y, Soga K, Wakabayashi T, &, FG F, (2009b): Angiographic changes after bevacizumab. Ophthalmology 116: 2263-2264.
    • (2009) Ophthalmology , vol.116 , pp. 2263-2264
    • Ikuno, Y.1    Soga, K.2    Wakabayashi, T.3    Fg, F.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.